Insider Stock Trading History of Ho Peter Tai-ching


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Ho Peter Tai-ching since year 2005. The trader's CIK number is 1619052. At the time of this reporting, Ho Peter Tai-ching is the Chief Development Officer of Epizyme, Inc. . (stock ticker symbol EPZM). See this page for all insider trading activities at Epizyme, Inc. .


Stock purchases, sales, and option exercises reported by insider Ho Peter Tai-ching since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-10-24 EPZM Epizyme, Inc. Option Ex 15,000 8.98 134,700
2017-10-24 EPZM Epizyme, Inc. Sale 15,000 16.44 246,585
2017-09-25 EPZM Epizyme, Inc. Option Ex 15,000 8.98 134,700
2017-09-25 EPZM Epizyme, Inc. Sale 15,000 16.80 252,075
2017-08-24 EPZM Epizyme, Inc. Option Ex 15,000 8.98 134,700
2017-08-24 EPZM Epizyme, Inc. Sale 15,000 15.68 235,260
2017-07-24 EPZM Epizyme, Inc. Option Ex 15,000 8.98 134,700
2017-07-24 EPZM Epizyme, Inc. Sale 15,000 13.44 201,570
2017-06-26 EPZM Epizyme, Inc. Option Ex 15,000 8.98 134,700
2017-06-26 EPZM Epizyme, Inc. Sale 15,000 14.87 223,110
2017-05-25 EPZM Epizyme, Inc. Option Ex 15,000 8.98 134,700
2017-05-25 EPZM Epizyme, Inc. Sale 15,000 16.11 241,665
2016-12-08 EPZM Epizyme, Inc. Sale 200 10.89 2,178
2015-12-09 EPZM Epizyme, Inc. Buy 1,000 14.69 14,690
2015-08-31 EPZM Epizyme, Inc. Buy 522 17.00 8,874
2015-08-20 EPZM Epizyme, Inc. Buy 2,000 16.51 33,020
2015-05-05 EPZM Epizyme, Inc. Buy 800 16.36 13,084
2014-12-16 EPZM Epizyme, Inc. Buy 400 17.63 7,052
2014-12-02 EPZM Epizyme, Inc. Buy 1,000 21.17 21,172

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ho Peter Tai-ching (Chief Development Officer of Epizyme, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.